CN Patent

CN1378448A — 多晶型托拉塞米

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2002-11-06 · 24y expired

What this patent protects

本发明涉及新型托拉塞米,表示为V型、无定形托拉塞米、Dupont2型溶剂加合物、Dupont 2型乙醇加合物和Dupont 2型异丙醇加合物。还公开它们的制备方法。本发明还涉及制备托拉塞米变型(I)的方法。还公开含有新型托拉塞米的药用组合物以及应用它们的方法。

USPTO Abstract

本发明涉及新型托拉塞米,表示为V型、无定形托拉塞米、Dupont2型溶剂加合物、Dupont 2型乙醇加合物和Dupont 2型异丙醇加合物。还公开它们的制备方法。本发明还涉及制备托拉塞米变型(I)的方法。还公开含有新型托拉塞米的药用组合物以及应用它们的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN1378448A
Jurisdiction
CN
Classification
—
Expires
2002-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.